Meningioma 1 anticorps
Aperçu rapide pour Meningioma 1 anticorps (ABIN7116478)
Antigène
Voir toutes Meningioma 1 (MN1) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Fonction
- MN1 antibody
-
Purification
- Immunogen affinity purified
-
Pureté
- ≥95 % as determined by SDS-PAGE
-
Immunogène
- meningioma(disrupted in balanced translocation) 1
-
Isotype
- IgG
-
-
-
-
Indications d'application
- IHC: 1:20-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freeze / thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C for 12 months
-
Date de péremption
- 12 months
-
-
- Meningioma 1 (MN1) (MN1 proto-oncogene (MN1))
-
Autre désignation
- MN1
-
Sujet
-
Synonyms: Transcriptional activator MN1|Probable tumor suppressor protein MN1|MN1
Background: Transcriptional activator which specifically regulates expression of TBX22 in the posterior region of the developing palate. Required during later stages of palate development for growth and medial fusion of the palatal shelves. Promotes maturation and normal function of calvarial osteoblasts, including expression of the osteoclastogenic cytokine TNFSF11/RANKL. Necessary for normal development of the membranous bones of the skull(By similarity). May play a role in tumor suppression(Probable).
-
ID gène
- 4330
-
UniProt
- Q10571
Antigène
-